한글목차

세계의 의료용 아산화질소 시장 규모는 2023년 18억 달러에서 예측 기간 동안 6.6%의 연평균 복합 성장률(CAGR)로 성장하여 2029년에는 28억 달러 규모로 성장할 것으로 예상됩니다.

시장 성장은 노인 인구 증가, 의료 인프라의 발전, 비침습적 통증 완화에 대한 수요, 의료용 가스 사용 관리에 대한 규제 강화 등 다양한 요인에 의해 촉진되고 있습니다. 또한, 선진국과 개발도상국 모두에서 수술 건수가 크게 증가하고 있으며, 이는 마취 및 진통에 의료용 아산화질소 사용을 증가시켜 산업이 더욱 성장할 수 있는 길을 열어주고 있습니다.

유형별로는 가스 부문이 2023년 가장 큰 점유율을 차지할 것으로 보입니다. 아산화질소 가스의 보급은 특히 수술 중 마취 및 진통에 사용되기 때문입니다. 의료 환경에서 가스가 선호되는 이유는 투여가 용이하고, 용량을 정확하게 제어할 수 있으며, 작용이 빠르게 나타나기 때문입니다.

용도별로는 마취 및 진통제 부문이 예측 기간 동안 가장 큰 성장세를 보일 것으로 예상됩니다. 마취 및 진통 부문의 우위는 수술 및 의료 시술에서 매우 중요한 역할을 수행하기 때문입니다. 아산화질소는 신속하고 제어 가능한 진정을 제공하여 환자의 편안함과 시술의 성공률을 크게 향상시키기 때문에 의료 전문가들이 널리 사용하고 있다는 점이 이러한 장점을 강조하고 있습니다.

지역별로는 북미가 예측 기간 동안 가장 큰 규모를 보일 것으로 예상됩니다. 반면, 아시아태평양은 예측 기간 동안 가장 빠른 성장을 보일 것으로 예상됩니다.

세계의 의료용 아산화질소(Nitrous Oxide) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 및 특허 동향, 규제 환경, 사례 연구, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 업계 동향
• 기술 분석
• 가격 분석
• Porter의 Five Forces 분석
• 관세 및 규제 분석
• 밸류체인 분석
• 생태계 분석
• 사례 연구 분석
• 특허 분석
• 주요 이해관계자와 구입 기준
• 주요 컨퍼런스 및 이벤트
• 무역 분석
• 고객의 비즈니스에 영향을 미치는 동향/파괴적 변화
• 미충족 요구 분석

제6장 의료용 아산화질소 시장 : 유형별

• 액체 아산화질소
• 가스 아산화질소

제7장 의료용 아산화질소 시장 : 용도별

• 마취 및 진통
• 동결 수술
• 외과적 주입

제8장 의료용 아산화질소 시장 : 최종사용자별

• 병원
• 홈케어
• 학술연구기관

제9장 의료용 아산화질소 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 기업의 전략/유력 기업
• 매출 분석
• 시장 점유율 분석
• 시장 순위 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 브랜드/제품 비교
• 기업 평가와 재무지표
• 경쟁 시나리오

제11장 기업 개요

• 주요 기업
  • AIR LIQUIDE
  • LINDE PLC
  • SOL SPA
  • TAIYO NIPPON SANSO CORPORATION
  • NORCO INC.
  • SOUTHERN GAS LIMITED
  • ELLENBARRIE INDUSTRIAL GASES
  • CALOX INC.
  • STEELMAN GASES PVT. LTD.
  • NEXAIR
  • OXYGEN & ARGON WORKS LTD.
  • GULFCRYO
  • CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
  • JIANGSU HUAZHONG GAS CO., LTD.
  • CARBIDE AND CHEMICALS
  • AMERICAN WELDING & GAS
  • ASIA INDUSTRIAL GASES PTE. LTD.
  • MIDDLESEX GASES & TECHNOLOGY INC.
  • AMERITANX CYLINDERS
  • CRYOCARB
• 기타 기업
  • HOLSTON GASES
  • AOPL
  • BUTLER GAS PRODUCTS COMPANY
  • GRUPPO SIAD
  • ANDY OXY CO., INC.

제12장 부록

영문목차

The global medical nitrous oxide market size is estimated to be USD 2.8 billion by 2029, from USD 1.8 billion in 2023, at a CAGR of 6.6%. The expansion of the medical nitrous oxide market is primarily fueled by various factors, including the increasing elderly population, advancements in healthcare infrastructure, a desire for non-invasive pain relief methods, and the existence of supportive regulations governing medical gas usage. Furthermore, the surge in surgical procedures, evident in both developed and developing nations, creates a favorable opportunity for the heightened utilization of medical nitrous oxide in anesthesia and analgesia, paving the way for additional growth prospects in the industry.

"The gasesous segment is expected to account for the largest market share in 2023."

The medical nitrous oxide market is segmented based on product into gaseous and liquid states. As of 2023, the gaseous segment dominated the market. The prevalence of the gaseous state in the medical nitrous oxide market is attributed to its versatility in applications, particularly in anesthesia and analgesia during surgical procedures. The preference for the gaseous form in medical environments is driven by its ease of administration, precise dosage control, and rapid onset of action.

"The anesthesia and pain relief segment to register the highest growth rate in the forecast period."

The medical nitrous oxide market, by application is segmented into anesthesia and pain relief, cryosurgery, and surgical insufflation. As of 2023, the anesthesia and pain relief segment is expected to register the highest growth during the forecast period. The dominance of anesthesia and pain relief applications in the medical nitrous oxide market is credited to their pivotal roles in both surgical and medical procedures. Nitrous oxide, celebrated for its anesthetic and analgesic properties, is widely embraced in healthcare settings due to its effectiveness in inducing conscious sedation and relieving pain during various medical interventions. This dominance is emphasized by the widespread use of nitrous oxide by healthcare professionals, as it offers swift and controllable sedation, significantly enhancing patient comfort and procedural success.

The hospital segment accounted for the largest share of the brain monitoring market in 2023.

The medical nitrous oxide market is classified by end user into hospitals, home healthcare, and academic and research institutions. As of 2023, the hospitals segment dominated the market. This is primarily due to the crucial role of nitrous oxide within hospital settings, particularly in the context of surgical and medical procedures. Hospitals, serving as central hubs for comprehensive healthcare services, extensively employ nitrous oxide for anesthesia and analgesia, offering a controlled and effective method for patient sedation during surgical interventions.

"North America to be the largest regional segment in the medical nitrous oxide market during the forecast period."

Based on the region, the global medical nitrous oxide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest share of the market in 2023. The Asia Pacific region is anticipated to experience the most rapid growth during the forecast period. The significant expansion of the market in the Asia Pacific can be attributed to the dynamic growth in healthcare infrastructure, a rise in surgical procedures, and an increasing awareness of the advantages of nitrous oxide. These factors collectively contribute to an increased demand for medical nitrous oxide in the APAC region.

Breakdown of primaries

The break of primary participants was as mentioned below:

• By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
• By Designation - C-level-35%, Director-level-25%, Others-40%
• By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

The medical nitrous oxide market is dominated by a few globally established players such as Carbide and Chemicals (India), nexAir (US), Air Liquide (Paris), Linde plc (Ireland), Southern Gas Limited (India), Jiangsu Huazhong Gas Co., Ltd. (China), American Welding & Gas (US), Oxygen & Argon Works Ltd (Israel), Matheson Tri-Gas Inc. (US), CalOx (US), Steelman Gases Pvt. Ltd. (India), Earlbeck Gases & Technology (US), Chengdu Taiyu Industrial Gases Co., Ltd. (China), Messer SE & CO. KGAA (Germany), SOL SpA (Italy), Ellenbarrie Industrial Gases (India), Norco Inc. (US), and Gulf Cryo (UAE).

Research Coverage:

The report segments the medical nitrous oxide market based on region (Asia Pacific, Europe, North America, Latin America, and Middle East & Africa), Product (gasesous, liquid), application (anesthesia and pain relief, cryosurgery, and surgical inflation), and end user(hospitals, home healthcare, and academic and research institutions).

The report also provides a comprehensive review of market drivers, restraints, and opportunities in the medical nitrous oxide market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical nitrous oxide market and provides them with information on key market drivers, restraints, challenges, and opportunities.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

.

• Analysis of key drivers (growing aging population, advancements in healthcare infrastructure, demand for non-invasive methods for pain relief, and supportive regulations and standards regarding the use of medical gases), restraints (safery concerns, availability of alternatives, environmental concerns), opportunities (emerging markets, pediatric applications), challenges (limited awareness, economic factors).
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global medical nitrous oxide market. The report analyzes this market by products, application, and end users.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global medical nitrous oxide market
• Market Development: Comprehensive information on the lucrative emerging markets by products, application, and end users.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global medical nitrous oxide market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global medical nitrous oxide market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKETS COVERED
  • FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION
  • 1.3.1 REGIONAL SEGMENTATION
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews: by company type, designation, and region
• 2.2 MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• 2.3 MARKET ESTIMATION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A.
  • FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING
  • FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023-2029)
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
• 2.5 STUDY ASSUMPTIONS
• 2.6 LIMITATIONS
  • 2.6.1 SCOPE-RELATED LIMITATIONS
  • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT
  • TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET
• 2.8 MEDICAL NITROUS OXIDE MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY

• FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION)
• FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
• FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
• FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET

4 PREMIUM INSIGHTS

• 4.1 MEDICAL NITROUS OXIDE MARKET OVERVIEW
  • FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH
• 4.2 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE AND COUNTRY (2022)
  • FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
• 4.3 MEDICAL NITROUS OXIDE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 MEDICAL NITROUS OXIDE MARKET: REGIONAL MIX
  • FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• 4.5 MEDICAL NITROUS OXIDE MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing number of surgeries and dental procedures
    • 5.2.1.2 Growing adoption of nitrous oxide across various medical specialties
    • 5.2.1.3 Rising geriatric population and subsequent increase in prevalence of chronic diseases
  • FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010-2030 (% OF TOTAL POPULATION)
    • 5.2.1.4 Growing demand for home healthcare
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Potential risks associated with nitrous oxide misuse
    • 5.2.2.2 Availability of alternatives
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising demand for pain management
  • FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019-2021
    • 5.2.3.2 Technological advancements
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Changes in calibration standards
    • 5.2.4.2 Lack of awareness
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS
  • 5.3.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Nitrous oxide delivery systems
    • 5.4.1.2 Monitoring and control systems
    • 5.4.1.3 Technological integration in anesthesia machines
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Patient monitoring devices
    • 5.4.2.2 Smart devices and connectivity
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Advanced anesthetic agents
    • 5.4.3.2 Surgical robotics
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT
  • TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD)
  • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6.2 BARGAINING POWER OF SUPPLIERS
  • 5.6.3 BARGAINING POWER OF BUYERS
  • 5.6.4 THREAT OF SUBSTITUTES
  • 5.6.5 THREAT OF NEW ENTRANTS
• 5.7 TARIFF & REGULATORY ANALYSIS
  • 5.7.1 TARIFF FOR MEDICAL NITROUS OXIDE
  • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7.3 NORTH AMERICA
    • 5.7.3.1 US
  • TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.7.3.2 Canada
  • TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7.4 EUROPE
  • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • 5.7.5 ASIA PACIFIC
    • 5.7.5.1 Japan
  • TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.7.5.2 China
  • TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT
  • TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.7.5.3 India
  • TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT
  • TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7.6 LATIN AMERICA AND MIDDLE EAST & AFRICA
  • TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.8 VALUE CHAIN ANALYSIS
  • FIGURE 22 VALUE CHAIN ANALYSIS
• 5.9 ECOSYSTEM ANALYSIS
  • TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING
  • FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT)
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS
  • FIGURE 24 PATENT PUBLICATION TRENDS, 2014-2024
  • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014-2024)
  • TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS
  • 5.11.3 MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS
  • FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014-2024)
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS
  • 5.12.2 BUYING CRITERIA
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET
  • TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET
• 5.13 KEY CONFERENCES & EVENTS IN 2024
  • TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
• 5.14 TRADE ANALYSIS
  • 5.14.1 TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE
  • FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
  • FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET
• 5.16 UNMET NEEDS ANALYSIS
  • TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET
  • 5.16.1 END-USER EXPECTATIONS
  • TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET

6 MEDICAL NITROUS OXIDE MARKET, BY TYPE

• 6.1 INTRODUCTION
  • TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• 6.2 LIQUID NITROUS OXIDE
  • 6.2.1 RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET
  • TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 GASEOUS NITROUS OXIDE
  • 6.3.1 PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH
  • TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 7.2 ANESTHESIA & PAIN RELIEF
  • 7.2.1 WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET
  • TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 CRYOSURGERY
  • 7.3.1 PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION
  • TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 SURGICAL INSUFFLATION
  • 7.4.1 USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET
  • TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022-2029 (USD MILLION)

8 MEDICAL NITROUS OXIDE MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 8.2 HOSPITALS
  • 8.2.1 EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET
  • TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 HOME CARE SETTINGS
  • 8.3.1 HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES
  • TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.4 ACADEMIC & RESEARCH INSTITUTES
  • 8.4.1 COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH
  • TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)

9 MEDICAL NITROUS OXIDE MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018-2021 (USD MILLION)
  • TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
  • TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American medical nitrous oxide market
  • TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Stringent regulatory compliance to support market growth in Canada
  • TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3 EUROPE
  • 9.3.1 EUROPE: RECESSION IMPACT
  • TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.2 GERMANY
    • 9.3.2.1 Increasing healthcare spending to drive market
  • TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Increasing surgeries & dental procedures to drive market
  • TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.4 FRANCE
    • 9.3.4.1 Well-established healthcare system to drive market
  • TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.5 ITALY
    • 9.3.5.1 Rapid growth in geriatric population and rising life expectancy to favor market growth
  • TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.6 SPAIN
    • 9.3.6.1 Increasing prevalence of cancer to support market growth
  • TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.7 REST OF EUROPE
  • TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
  • TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.2 JAPAN
    • 9.4.2.1 Japan to hold largest share of APAC market
  • TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.3 CHINA
    • 9.4.3.1 Strong investments in infrastructural development to offer opportunities for market growth
  • TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Rising procedural volume to ensure sustained demand for medical gases
  • TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.5 REST OF ASIA PACIFIC
  • TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.5 LATIN AMERICA
  • 9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE
  • 9.5.2 LATIN AMERICA: RECESSION IMPACT
  • TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
  • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018-2021 (USD MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022-2029 (USD MILLION)

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET
• 10.3 REVENUE ANALYSIS
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018-2022 (USD MILLION)
• 10.4 MARKET SHARE ANALYSIS
  • FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022)
  • TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION
• 10.5 MARKET RANKING ANALYSIS
  • FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022
• 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.6.1 STARS
  • 10.6.2 EMERGING LEADERS
  • 10.6.3 PERVASIVE PLAYERS
  • 10.6.4 PARTICIPANTS
  • FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 10.6.5 COMPANY FOOTPRINT
  • FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT
  • TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT
  • TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT
  • TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT
  • TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT
• 10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 10.7.1 PROGRESSIVE COMPANIES
  • 10.7.2 RESPONSIVE COMPANIES
  • 10.7.3 DYNAMIC COMPANIES
  • 10.7.4 STARTING BLOCKS
  • FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 10.7.5 COMPETITIVE BENCHMARKING
    • 10.7.5.1 Detailed list of key startups/SMEs
  • TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES
    • 10.7.5.2 Competitive benchmarking of key startups/SMEs
  • TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPANY EVALUATION AND FINANCIAL METRICS
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 DEALS
  • TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020- JANUARY 2024
  • 10.10.2 EXPANSIONS
  • TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020-JANUARY 2024

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 11.1.1 AIR LIQUIDE
• TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW
• FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
• 11.1.2 LINDE PLC
• TABLE 165 LINDE PLC: COMPANY OVERVIEW
• FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022)
• 11.1.3 SOL SPA
• TABLE 166 SOL SPA: COMPANY OVERVIEW
• FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022)
• 11.1.4 TAIYO NIPPON SANSO CORPORATION
• TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW
• FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023)
• 11.1.5 NORCO INC.
• TABLE 168 NORCO INC.: COMPANY OVERVIEW
• 11.1.6 SOUTHERN GAS LIMITED
• TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW
• FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022)
• 11.1.7 ELLENBARRIE INDUSTRIAL GASES
• TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW
• FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020)
• 11.1.8 CALOX INC.
• TABLE 171 CALOX INC.: COMPANY OVERVIEW
• 11.1.9 STEELMAN GASES PVT. LTD.
• TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW
• 11.1.10 NEXAIR
• TABLE 173 NEXAIR: COMPANY OVERVIEW
• 11.1.11 OXYGEN & ARGON WORKS LTD.
• TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW
• 11.1.12 GULFCRYO
• TABLE 175 GULFCRYO: COMPANY OVERVIEW
• 11.1.13 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
• TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW
• 11.1.14 JIANGSU HUAZHONG GAS CO., LTD.
• TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW
• 11.1.15 CARBIDE AND CHEMICALS
• TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW
• 11.1.16 AMERICAN WELDING & GAS
• TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW
• 11.1.17 ASIA INDUSTRIAL GASES PTE. LTD.
• TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW
• 11.1.18 MIDDLESEX GASES & TECHNOLOGY INC.
• TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW
• 11.1.19 AMERITANX CYLINDERS
• TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW
• 11.1.20 CRYOCARB
• TABLE 183 CRYOCARB: COMPANY OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 11.2 OTHER PLAYERS
  • 11.2.1 HOLSTON GASES
  • 11.2.2 AOPL
  • 11.2.3 BUTLER GAS PRODUCTS COMPANY
  • 11.2.4 GRUPPO SIAD
  • 11.2.5 ANDY OXY CO., INC.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS